Elevated risk of new-onset chronic fatigue syndrome/myalgic encephalomyelitis up to four years after SARS-CoV-2 infection

Elevated risk of new-onset chronic fatigue syndrome/myalgic encephalomyelitis up to four years after SARS-CoV-2 infection

Publication date: Jul 24, 2025

Some prior studies have reported a higher risk of long-COVID in patients re-infected with SARS-CoV-2 [64,65,66], but none investigated risk of CFS/ME. found no difference in risk of CFS/ME onset , suggesting COVID-19 per se may not exert higher risk of CFS/ME compared to other respiratory infections. Many of these individuals might have inherently been at higher risk of developing CFS/ME. We found no association between CFS/ME risk and key blood biomarkers obtained during acute COVID-19. Patients could be misclassified as COVID if they were tested positive elsewhere and such misclassification likely underestimated any potential impact of the infection on the outcome. Vaccination for COVID-19 was associated with an increased risk of new-onset CFS/ME, but only among individuals who received the vaccine during the initial phase of the rollout. Alternatively, the observed lower incidence in non-White populations may reflect diagnostic disparities driven by systemic bias in healthcare settings . Females, patients with liver, autoimmune disorders, and anxiety disorders were more likely to develop the outcome.

Concepts Keywords
German Cfs
Hispanic Cov
Underserved Covid
Vaccines Disorders
Fatigue
Findings
Higher
Hospitalized
Infection
New
Onset
Post
Reported
Risk
Sars

Semantics

Type Source Name
disease IDO susceptibility
disease MESH misdiagnosis
disease IDO acute infection
disease IDO blood
disease MESH Re-infection
disease MESH anxiety disorders
disease MESH infection
disease MESH respiratory infections
disease IDO history
disease MESH Long Covid
disease MESH education level
disease MESH relapse
pathway REACTOME SARS-CoV-2 Infection
disease MESH SARS-CoV-2 infection
disease MESH chronic fatigue syndrome
disease MESH COPD
disease MESH liver disease
disease MESH causality
disease MESH anxiety
disease MESH depressive disorder
disease MESH cognitive dysfunction
disease IDO role

Original Article

(Visited 2 times, 1 visits today)